Cysteine-depleted peptides recognized by a3-restricted...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/63 (2006.01) A61K 31/70 (2006.01) A61K 48/00 (2006.01) C07K 7/00 (2006.01) C07K 7/04 (2006.01) C07K 14/705 (2006.01) C12N 5/06 (2006.01)

Patent

CA 2278931

Cysteine-depleted CTL epitopes can elicit a stronger or more specific CTL response than the native, cysteine-containing CTL epitope of a disease associated antigen.

Des déterminants antigéniques de lymphocytes T cytotoxiques (CTL) appauvris en cystéine peuvent déclencher une réaction de CTL plus importante ou plus spécifique que le déterminant antigénique natif de CTL contenant cystéine d'un antigène associé à une maladie.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Cysteine-depleted peptides recognized by a3-restricted... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cysteine-depleted peptides recognized by a3-restricted..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cysteine-depleted peptides recognized by a3-restricted... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1481354

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.